FREQUENCY OF HYPERURICEMIA IN PATIENTS WITH HEART DISEASES
Main Article Content
Keywords
Hyperuricemia, hypertensive heart disease, ischemic heart disease
Abstract
Background: Uric acid is an active chemical compound because it has a biological role in a variety of physiological activities. It's unclear how high blood uric acid levels and cardiovascular disorders are related to one another. Research is needed to identify a potential dual effect in the cardiovascular system between the rising or lowering of serum uric acid and the development of heart diseases.
Objective: To study the frequency of hyperuricemia in patients with Ischemic heart disease and hypertensive heart disease.
Methods: A non-probability convenient selection approach was used to pick 150 patients with heart disorders who were hospitalized in the cardiac unit in multicenter hospitals, based on predetermined inclusion and exclusion criteria for this cross-sectional study. 150 patients who were hospitalized at the tertiary care hospital were included and their serum uric acid was recorded and observed the relation to heart diseases.
Results: The mean age of participants in this study was 59 ± SD 11.4 years. In this study, 100 patients were male while 50 were female. The most frequently found heart disease among the subjects was Ischemic Heart Disease (46.2%) while hypertensive heart disease (33%). A total of 25 individuals having Ischemic heart disease had Hyperuricemia while 16 individuals had hypertensive heart disease and four with both observed Hyperuricemia.
Conclusion: Our investigation's results indicate that hyperuricemia is quite common in people with ischemic and hypertensive heart disease.
References
2. Mehmet Kanbay MS, Afsar B. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart 2013;99:759–756.
3. Zhao G, Huang L, Song M, Song Y. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and allcause mortality: a meta-analysis of prospective studies. Atherosclerosis 2013;231(1):61–8.
4. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta‐analysis. Arthritis Care & Research: Official J Am Coll Rheumatol 2010;62(2):170–80.
5. Wheeler JG, Juzwishin KDM, Eiriksdottir G, Gudnason V, Danesh J. Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and metaanalysis. PLoS Med 2005;2(3):e76.
6. Members WG, Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113(6):e85–151.
7. Kuwabara M. Hyperuricemia, cardiovascular disease, and hypertension. Pulse 2015;3(3–4):242– 52. 8. Gavin AR, Struthers AD. Hyperuricemia and adverse outcomes in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovascular Drugs 2003;3:309–14.
8. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. ProcNatlAcadSci U S A. 1981; 78: 6858-62.
9. Liese AD, Hense HW, Lowel H, Doring A, Tietze M, Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. Epidemiology. 1999; 10: 391-7.
10. Alderman M, Aiyer KJV. Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin. 2004; 20:369-79.
11. Sundstrom J, Sullivan L, D’Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005; 45:28-33.
12. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, et al. Uric acid and the development of hypertension. Hypertension. 2006; 48:1031-6.
13. Bos MJ, Koudstaal PJ, Hofman A, Witteman JCM, Breteler MMB. Uric acid is a risk factor for myocardial infarction and stroke:the Rotterdam study. Stroke. 2006; 37:1503-7.
14. Deveci OS, Kabakci G, Okutucu S, Tulumen E, Aksoy H, Kaya EB, et al. The association between serum uric acid level and coronary artery disease. Int J ClinPract. 2010; 64: 900-7.
15. Strasak AM, Kelleher CC, Brant LJ, et al. VHM&PP study group. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year fol- low-up study. Int J Cardiol. 2008; 125: 232-9.
16. Thanassoulis G, Brophy JM, Richard H, Pilote L. Gout, allopurinol use, and heart failure outcomes. Arch Intern Med. 2010; 170: 1358-64.
17. Kivity S, Kopel E, Maor E, Abu-Bachar F, Segev S, Sidi Y and Olchovsky D. Association of serum uric acid and cardiovascular disease in healthy adults. Am J Cardiol. 2013; 111: 1146-1151.
18. Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM, Arauz A, Orozco-Valera DR, Ochoa- Guzmán A, Villarreal-Careaga J, León-Jiménez, Barina-garre- menteria F, Ramos-Moreno A and Cantú-Brito C. Serum Uric Acid and Outcome after Acute Ischemic Stroke-PREMIER Study. Cerebrovasc Dis. 2013; 35:168-174.
19. Rosendorff C and Jogendra MRD. Uric Acid: Where Are We? The Journal of Clinical Hypertension. 2013; 15.
20. Davies KJ, Sevanian A, Muakkassah-Kelly SF and Hochstein P . Uric acid iron ion complexes. A new aspect of the antioxidant functions of uric acid. Bio- chem J. 1986; 235: 747–754.
21. Nieto FJ, Iribarren C, Gross MD, Comstock GW and Cutler RG. Uric acid and serum antioxidant capac- ity: a reaction to atherosclerosis? Atherosclerosis. 2000;148: 131–9.
22. Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, Mancini M and TrevisanM. Serum uric acid and hypertension: the Olivetti heart study. J Hum Hypertens. 1994; 8:668-77.
23. Heinig M and Johnson RJ. Role of uric acid in hy- pertension, renal disease and metabolic syndrome. Cleve Clin J Med. 2006; 73: 1059-63.
24. Johnson RJ, Kang DH, Feig D et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertens. 2003; 41:1183–90.
25. Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the ratby a novel crystal-independent mechanism. Hypertension. 2001; 38:1101–1106.
26. Hsu PF, Chuang SY, Yu WC, Leu HB, Chan WL and Chen CH. The Impacts of Serum Uric Acid on arterial hemodynamics and Cardiovascular Risks. ActaCardiol Sin. 2013; 29:142-50.
27. Brodov Y, Chouraqui P, Goldenberg I, BoykoV, Mandelzweig L, Behar S. Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology. 2009; 114(4): 300-5.
28. Wiik BP, Larstorp AC, Høieggen A, Kjeldsen SE, Ol- sen MH, Ibsen H, et al. Serumuric acid is associated with new-onset diabetes in hypertensive patients with leftventricular hypertrophy: The LIFE Study. Am J Hypertens. 2010; 23 (8): 845-51.
29. Rodrigues SL, Baldo MP, Sá Cunha R, Angelo LC, Pereira AC, Krieger JE, et al. Anthropometric mea- sures of increased central and overall adiposity in association with echocardiographic left ventricular hypertrophy. Hypertens Res. 2010; 33 (1): 83-7.
30. Rodrigues SL, Baldo MP, Mill JG. Association of waist-stature ratio with hypertension andmetabolic syndrome: population-based study. Arq Bras Car- diol. 2010; 95 (2): 186-91.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Muhammad Usman Khan
Cumberland Infirmary, Carlisle UK.
Khushbakht Shahjahan
University of Health Sciences, Lahore, Pakistan, Rahber Medical and Dental College, Lahore, Pakistan, Internship Rangers Teaching Hospital.
Muhammad Aqeel
House Officer Internal Medicine, Lady Reading Hospital Peshawar.
Qazi Muhammad Farooq Wahab
Resident General Medicine, Hayatabad Medical Complex Peshawar.
Rameen
Internship General Medicine Prime Teaching Hospital, Peshawar.
Waqar Khan
House Officer General Medicine, Hayatabad Medical Complex, Peshawar.